Lareya

Lareya

leflunomide

Manufacturer:

Sriprasit Pharma

Distributor:

SPS Medical

Marketer:

SPS Medical
Concise Prescribing Info
Contents
Leflunomide
Indications/Uses
RA, psoriatic arthritis.
Dosage/Direction for Use
RA 100 mg for 3 days, then 10-20 mg once daily. Psoriatic arthritis 100 mg for 3 days, then 20 mg once daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Patient w/ hepatitis B or C. Renal failure, bone marrow dysplasia, severe uncontrolled infection. Pregnancy.
Special Precautions
Check hepatic enzymes (ALT) prior to initiation of treatment & every 6 mth; after treatment & every 6-8 wk.
Adverse Reactions
Increased hepatic enzymes (AST, ALT), diarrhea, nausea, alopecia, pruritus, rash, headache, dizziness, HTN.
Drug Interactions
Rifampin.
ATC Classification
L04AA13 - leflunomide ; Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.
Presentation/Packing
Form
Lareya tab 20 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in